Eczema

Eczema or atopic dermatitis is a long-lasting, itchy inflammatory condition of the skin which may become red, dry, blistered, crusted, scaly or thickened.

What is Eczema?

Eczema or atopic eczema is a skin condition characterized by chronic inflammation and frequent relapses. There are itchy red rashes over the affected areas that usually involve skin creases such as the folds of the elbows or behind the knees.

Eczema Types

Eczema Treatment

Eczema Research

Eczema Triggers

Eczema and Vaccinia Virus

Eczema in babies

Effects of Dry Skin

Childhood Eczema and Mental Health: Where is the Link?

Eczema During Pregnancy

Differentiating Between Eczema and a Rash

Nitric Oxide as a Treatment for Eczema / Other Skin Conditions

Latest Eczema News and Research

Novel treatment for inflammatory skin conditions could be on the horizon

A new approach to treat rosacea and other inflammatory skin conditions could be on the horizon, according to a University of Pittsburgh study published today in Science Translational Medicine.

11 Dec 2024

Dupilumab improves symptoms of atopic dermatitis in children with co-existing conditions

Research at National Jewish Health and other institutions has shown that the biologic dupilumab improves signs and symptoms of moderate-to-severe atopic dermatitis (eczema) in young children whether or not they have another inflammatory condition, such as asthma, allergic rhinitis or food allergies.

5 Dec 2024

Fine particulate matter linked to higher eczema risk

Researchers explore the association between exposure to fine particulate matter and the risk of eczema.

20 Nov 2024

Increased air pollution tied to higher eczema risk

People living in areas with higher levels of air pollution are more likely to have eczema, according to a new study published November 13, 2024 in the open-access journal PLOS ONE by Dr. Jeffrey Cohen of Yale School of Medicine, USA.

13 Nov 2024

Vitamin D supplements during pregnancy strengthen children's bones

Children whose mothers took extra vitamin D during pregnancy continue to have stronger bones at age seven, according to new research led by the University of Southampton and University Hospital Southampton (UHS).

6 Nov 2024

New therapeutic target overcomes ovarian cancer immunotherapy resistance

Researchers at the Icahn School of Medicine at Mount Sinai have discovered a way that ovarian cancer tumors manipulate their environment to resist immunotherapy and identified a drug target that could overcome that resistance.

1 Nov 2024

Research uncovers how parasitic worms evade itch response

Ever had an itchy nose or, worse, an unreachable spot on your back that drives you mad? Now imagine an itch that refuses to go away, no matter how hard or long you scratch.

26 Oct 2024

Study shows limited benefits of elimination diets for children with atopic dermatitis

Parents of children with atopic dermatitis (AD, also called eczema) know that the allergic condition can mean a heightened risk of developing food allergies.

24 Oct 2024

Gut health and diet: Keys to treating acne, alopecia, and dermatitis

Consuming diets rich in fiber, antioxidants, and phytonutrients, combined with the use of probiotics, synbiotics, and postbiotics, improves overall skin health.

24 Oct 2024

Study finds connection between air pollution and childhood peanut allergies

Exposure to higher levels of air pollution as a baby is linked to having a peanut allergy throughout childhood, according to a new study.

22 Oct 2024

New image database aims to improve dermatological diagnostics in Africa

In many countries in Africa, up to nine out of ten children suffer from a skin problem, and there are far too few local dermatologists. Artificial intelligence could help with diagnosis, but needs to be trained with the relevant images, so researchers have created a new data set for dark skin tones.

12 Oct 2024

Novel molecular signaling pathway found to play a crucial role in maintaining the skin barrier

Our skin–the body's largest organ–provides the first line of defense against infections and many other threats to our health.

9 Aug 2024

Almirall's Ebglyss recommended by NICE for NHS atopic dermatitis patients

Almirall S.A., a global biopharmaceutical company dedicated to medical dermatology, announced today that the National Institute for Health and Care Excellence (NICE) has recommended Ebglyss (lebrikizumab) for use in moderate to severe Atopic Dermatitis in the NHS England.

13 Jul 2024

FDA approved PDE4 inhibitor roflumilast for atopic dermatitis

On July 9th, 2024, the U.S. FDA approved Arcutis Biotherapeutics' ZORYVE® (roflumilast) for treating atopic dermatitis (AD), the most common type of eczema affecting millions in the U.S. This once-daily, steroid-free cream could become a new standard of care for AD.

From Sino Biological Inc. 12 Jul 2024